These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7341329)

  • 1. [Kanendomycin in respiratory tract infection. Comparative clinical study of other aminoglycosides].
    Ginesu F; Ortu AR; Puddu E; Schena G
    G Ital Chemioter; 1980; 27(2):69-80. PubMed ID: 7341329
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical tolerance of kanendomycin in otorhinolaryngology].
    Barberi G
    G Ital Chemioter; 1977; 24(1-2):15-6. PubMed ID: 615757
    [No Abstract]   [Full Text] [Related]  

  • 3. [Personal experience with kanendomycin in the treatment of various infectious bronchopulmonary diseases].
    Visentin G; Sapori L
    Clin Ter; 1983 Apr; 105(1):23-7. PubMed ID: 6851451
    [No Abstract]   [Full Text] [Related]  

  • 4. [Preliminary clinical studies on the efficacy and tolerance of kanendomycin in the pneumological field].
    Moreo GC; Comaschi GF
    G Ital Chemioter; 1976; 23(1):11-6. PubMed ID: 800999
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use in pneumology of a new antibiotic: kanendomycin].
    Giura R; Rossini G
    G Ital Chemioter; 1977; 24(1-2):11-4. PubMed ID: 615752
    [No Abstract]   [Full Text] [Related]  

  • 6. [Nephrotoxicity of aminoglycoside antibiotics].
    Giura R; Roccamo B; Donghi M; Landriscina M
    G Ital Chemioter; 1979; 26(1-2):297-300. PubMed ID: 554820
    [No Abstract]   [Full Text] [Related]  

  • 7. [Sisomycin--comparative pharmacokinetic studies and clinical experiences with a new aminoglycoside antibiotic].
    Lode H; Kemmerich B; Langmaack H
    Verh Dtsch Ges Inn Med; 1975; 81():1646-8. PubMed ID: 1227044
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical use of aminoglycosides].
    Mouton Y; Beaucaire G; Deboscker Y; Fourrier A
    LARC Med; 1983 Feb; 3(2):107-10. PubMed ID: 6855385
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative clinical trial of HBK and amikacin (AMK) in the treatment of respiratory infections].
    Hara K; Saito A; Yamaguchi K; Shigeno Y; Taira K; Oda T; Hayashi T; Tomita H; Masuyama Y; Saito A
    Kansenshogaku Zasshi; 1987 Jan; 61(1):22-53. PubMed ID: 3106530
    [No Abstract]   [Full Text] [Related]  

  • 10. [Refractory respiratory tract infections. 7. Trends in the development of new chemotherapeutic agents for respiratory tract infections. a. Antibiotics].
    Goto H; Shimada K
    Nihon Rinsho; 1987 Mar; 45(3):571-6. PubMed ID: 3298735
    [No Abstract]   [Full Text] [Related]  

  • 11. A randomized controlled clinical trial on etimicin, a new aminoglycoside antibiotic, versus netilmicin in the treatment of bacterial infections.
    Zhao C; Li J; Hou J; Guo M; Zhang Y; Chen Y
    Chin Med J (Engl); 2000 Nov; 113(11):1026-30. PubMed ID: 11776118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The treatment of cystic fibrosis].
    Fleer A; Roord JJ; van der Laag J
    Ned Tijdschr Geneeskd; 1986 Oct; 130(42):1910-1. PubMed ID: 3785462
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of enteritis with kanendomycin].
    Colomba A; Fundarò S; Pitruzzella E
    Minerva Pediatr; 1978 Jul; 30(13):1115-20. PubMed ID: 672853
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative studies on the problem of nephrotoxicity of the aminoglycosides: kanamycin, amikacin, butirosin and kanendomycin].
    Sack K; Züllich B; Eikenberg P
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1538-40. PubMed ID: 70900
    [No Abstract]   [Full Text] [Related]  

  • 15. [Serum concentrations and clinical efficacy of dibekacin after intravenous drip infusion to patients with respiratory tract infections].
    Soejima R; Niki Y; Matsushima T; Tano Y
    Jpn J Antibiot; 1982 Dec; 35(12):2773-7. PubMed ID: 7182533
    [No Abstract]   [Full Text] [Related]  

  • 16. [Refractory respiratory tract infections. 4. Selection of chemotherapeutic agents and their administration. c. Pseudomonas infections].
    Oizumi K
    Nihon Rinsho; 1987 Mar; 45(3):526-30. PubMed ID: 3298728
    [No Abstract]   [Full Text] [Related]  

  • 17. [Tobramycin: clinical and microbiological evaluation].
    Schoutens E; Vanderlinden MP; Yourassowsky E
    Acta Clin Belg; 1972; 27(5):578-84. PubMed ID: 4669780
    [No Abstract]   [Full Text] [Related]  

  • 18. [Kanendomycin in the treatment of urinary tract infections].
    Azzena D; Armani U; Trasciatti S
    G Ital Chemioter; 1977; 24(1-2):1-6. PubMed ID: 615750
    [No Abstract]   [Full Text] [Related]  

  • 19. [Secondary respiratory tract infections occurring in residual lesion of pulmonary tuberculosis. 4. Chemotherapy of secondary respiratory tract infections].
    Ooizumi K
    Kekkaku; 1986 Dec; 61(12):654-7. PubMed ID: 3573504
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical evaluation of the therapeutic effect of vistamycin and kanamycin on the various urinary tract infections--analysis by double blind method].
    Shishito S
    Hinyokika Kiyo; 1972 Mar; 18(3):160-72. PubMed ID: 4558366
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.